Emilio Sanchez-Fonseca - Publications

Effectiveness of the ALMA Intervention on Cognitive Function in Women with Breast Cancer: Protocol for a Randomized Controlled Trial.

Journal: Journal of clinical medicine

Published: May 27, 2026

Assessment of Muscle Function Decline and Cachexia-Related Biomarkers in Hospitalized Oncology Patients: Study Protocol.

Journal: Biomedicines

Published: May 18, 2026

ctDNA-derived copy-number signatures associated with immune checkpoint inhibitor resistance beyond PD-L1 and TMB in advanced NSCLC.

Journal: Frontiers in oncology

Published: May 08, 2026

Effects of a resistance training program on chemotherapy-induced peripheral neuropathy, cancer-related fatigue, muscle strength and physical activity in colorectal cancer patients undergoing chemotherapy: a pilot randomized controlled trial.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 18, 2026

8- versus 12-week supervised resistance training with home-based physical activity during colorectal cancer treatment: a pilot randomized dose-comparison trial.

Journal: BMC cancer

Published: March 17, 2026

Spanish adaptation and validation of Mishel's Uncertainty in Illness Scale (MUIS-A) in cancer patients.

Journal: BMC psychology

Published: February 19, 2026

A Complete Response to Immunotherapy in a Patient with Locally Advanced Squamous Cell Lung Cancer Harboring a Novel TMEM178B::BRAF Fusion: A Case Report.

Journal: Diagnostics (Basel, Switzerland)

Published: February 11, 2026

Effects of a 12-Week Supervised Exercise Program on Quality of Life, Functional Capacity, and Biological Parameters in Women with Breast Cancer: A Prospective Pilot Program.

Journal: Journal of clinical medicine

Published: January 18, 2026

Exploratory plasma ctDNA genomic biomarkers identified by whole-exome sequencing and a novel bioinformatics pipeline in advanced driver-negative NSCLC.

Journal: Scientific reports

Published: January 17, 2026

Two-year treatment-free sustained remission after chemo-immunotherapy in a 52-year-old male with recurrent ARID1A-mutant lung adenocarcinoma: a case report.

Journal: Translational lung cancer research

Published: January 09, 2026

Steroid-Refractory Cholestatic Immune-Mediated Hepatitis Following Nivolumab Therapy in an Elderly Patient with Metastatic Melanoma: A Rare and Challenging Presentation.

Journal: Current oncology (Toronto, Ont.)

Published: November 08, 2025

Effects of Resistance Exercise on Quality of Life, Anxiety, Depression, Sleep Quality and Inflammatory Parameters in Patients with Colorectal Cancer Undergoing Active Treatment: A Pilot Randomized Clinical Trial.

Journal: Current oncology (Toronto, Ont.)

Published: October 27, 2025